Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABILITY-3: Adalimumab Withdrawal in nr-axSpA
NCT01808118Phase 3Completed
- Sponsor
- AbbVie Inc.
- Start
- Apr 2013
- Primary completion
- Feb 2017
- Modality
- Monoclonal Antibodies
01
Overview
A Phase 3 trial of adalimumab in non-radiographic axial spondyloarthritis (nr-axSpA), sponsored by AbbVie Inc.. Started Apr 2013; status: completed.
02
Drugs
03
Conditions
non-radiographic axial spondyloarthritis (nr-axSpA)
Beyond the preview
Go deeper on NCT01808118.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01808118.